This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Industry Outlook Highlights Live Nation, News, Warner Music and IMAX
by Zacks Equity Research
LYV, NWSA, WMG, and IMAX are navigating rising content costs with strategic moves as digital media demand continues to climb.
4 Film & Television Production Stocks to Watch on Dull Industry Trends
by Vasundhara Sawalka
Film and television production and distribution companies like WMG, NWSA, LYV and IMAX are thriving due to the heightened consumption of digital entertainment despite heavy spending on original programming and exclusive rights.
Dolby Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y
by Zacks Equity Research
DLB beats Q3 earnings and revenue estimates as Dolby Atmos and Dolby Vision gain ground across devices and content.
Do Options Traders Know Something About IMAX Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to IMAX stock based on the movements in the options market lately.
Unlocking Imax (IMAX) International Revenues: Trends, Surprises, and Prospects
by Zacks Equity Research
Examine the evolution of Imax's (IMAX) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
IMAX Q2 Earnings Surpass Expectations, Revenues Increase Y/Y
by Zacks Equity Research
IMAX's second-quarter 2025 earnings beat estimates, with revenues rising year over year, driven by second-quarter box office gains.
Imax (IMAX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Imax (IMAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Imax (IMAX) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Imax (IMAX) delivered earnings and revenue surprises of +36.84% and +0.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Live Nation (LYV) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Live Nation (LYV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LYV's Concert Demand Remains Strong: Can it Handle Rising Costs?
by Zacks Equity Research
Live Nation rides strong concert demand and ticketing growth, but rising production costs can squeeze 2025 profitability.
Imax (IMAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Imax (IMAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Imax (IMAX) Up 15.5% Since Last Earnings Report?
by Zacks Equity Research
Imax (IMAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
International Markets and Imax (IMAX): A Deep Dive for Investors
by Zacks Equity Research
Review Imax's (IMAX) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
IMAX Q1 Earnings Surpass Expectations, Revenues Increase Y/Y
by Zacks Equity Research
IMAX first-quarter 2025 earnings beat estimates, with revenues rising year over year, driven by a record first-quarter box office.
Imax (IMAX) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Imax (IMAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Imax (IMAX) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Imax (IMAX) delivered earnings and revenue surprises of 18.18% and 3.57%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Imax (IMAX) Reports Next Week: What Awaits?
by Zacks Equity Research
Imax (IMAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Premium Formats Fuel AMC's 2025 Box Office High: How to Play the Stock
by Mrithunjoy Kaushik
AMC Entertainment's focus on premium formats, ongoing theater upgrades and customer experience enhancements position it well for growth.
AMC Entertainment Boosts Premium Offerings With IMAX Expansion
by Zacks Equity Research
AMC expands its IMAX partnership, bringing IMAX with Laser technology to over 180 AMC locations across the United States.
Why Is Imax (IMAX) Down 1.6% Since Last Earnings Report?
by Zacks Equity Research
Imax (IMAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Imax (IMAX) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Review Imax's (IMAX) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
IMAX Q4 Earnings Miss, Revenues Rise Y/Y on Box Office Gain
by Zacks Equity Research
IMAX's Q4 2024 results reflect growth in total revenues backed by strength in box office performance.
Imax (IMAX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Imax (IMAX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Imax (IMAX) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Imax (IMAX) delivered earnings and revenue surprises of -6.90% and 11.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Wall Street's Insights Into Key Metrics Ahead of Imax (IMAX) Q4 Earnings
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Imax (IMAX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.